e-learning
resources
Munich 2006
Sunday 03.09.2006
Smoking cessation: why and how
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cultural and clinical features of bacterial pneumonia in smoking patients: clinical and experimental study
A. S. Shprykov (Nizhny Novgorod, Russian Federation)
Source:
Annual Congress 2006 - Smoking cessation: why and how
Session:
Smoking cessation: why and how
Session type:
Thematic Poster Session
Number:
1441
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. S. Shprykov (Nizhny Novgorod, Russian Federation). Cultural and clinical features of bacterial pneumonia in smoking patients: clinical and experimental study. Eur Respir J 2006; 28: Suppl. 50, 1441
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Female gender is associated with poor clinical outcomes in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007
A clinical and outcomes assessment of the management of acute episodes of chronic bronchitis (AECB) : the MOSAIC study - baseline characteristics of screened patients
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002
The influence of CRB-65 and some clinical and epidemiological factors over approach to community acquired pneumonia
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Thrombocytosis predicts poor outcomes in patients with community-acquired pneumonia: results from the CAPO international cohort study
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
The presence of diabetes mellitus does not influence clinical outcomes in patient with community-acquired pneumonia: Results from the CAPO international cohort study
Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia
Year: 2010
Prospective evaluation of clinical and microbiological parameters in patients with community-acquired pneumonia with and without comorbidity
Source: Eur Respir J 2006; 28: Suppl. 50, 530s
Year: 2006
Community acquired pneumonia (CAP) in children at the age over 3yrs - clinical, etiological and radiological features
Source: Eur Respir J 2005; 26: Suppl. 49, 166s
Year: 2005
Community acquired pneumonia in the elderly: clinical aspects and prognostic factors
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006
A study of the relation of microbiological etiology with analytical and clinical parameters in exacerbation of COPD
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Clinical and inflammatory characteristics of patients with COPD in primary care: an observational study
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
The ARIETTA study: baseline demographics in a real-world setting in patients with severe asthma
Source: International Congress 2017 – Bronchial asthma management
Year: 2017
Clinical characteristics and outcomes of hospitalized COVID-19 pneumonia : impact of gender
Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19
Year: 2021
Severe community acquired pneumonia: clinical and aetiological evaluation
Source: Eur Respir J 2007; 30: Suppl. 51, 673s
Year: 2007
Clinical, radiological and functional outcomes in patients with COVID-19 pneumonia: A prospective observational study
Source: Virtual Congress 2021 – Imaging in COVID-19
Year: 2021
Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007
Early outcomes in CAP: clinical stability, clinical failure and nonresolving pneumonia
Source: Eur Respir Monogr 2014; 63: 205-218
Year: 2014
Association of demographic, laboratory and clinical parameters with HRCT-chest findings in patients with sarcoidosis.
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
A worldwide perspective of the level of compliance with guidelines in hospitalized patients with community-acquired pneumonia: results from the CAPO cohort international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
An RDW-based clinical model predicts long-term survival in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation multicentric study
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept